These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21238466)

  • 1. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats.
    Amitai N; Kuczenski R; Behrens MM; Markou A
    Neuropharmacology; 2012 Mar; 62(3):1422-31. PubMed ID: 21238466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
    Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
    Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
    Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
    Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jun; 375(4):261-71. PubMed ID: 17458542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal phencyclidine treatment induces behavioral deficits through impairment of GABAergic interneurons in the prefrontal cortex.
    Toriumi K; Oki M; Muto E; Tanaka J; Mouri A; Mamiya T; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2016 Jun; 233(12):2373-81. PubMed ID: 27095448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha(7) Nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment.
    Thomsen MS; Christensen DZ; Hansen HH; Redrobe JP; Mikkelsen JD
    Neuropharmacology; 2009; 56(6-7):1001-9. PubMed ID: 19233218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative modulation of GABAA α5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats.
    Redrobe JP; Elster L; Frederiksen K; Bundgaard C; de Jong IE; Smith GP; Bruun AT; Larsen PH; Didriksen M
    Psychopharmacology (Berl); 2012 Jun; 221(3):451-68. PubMed ID: 22124672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure.
    Amitai N; Semenova S; Markou A
    Eur J Pharmacol; 2009 Jan; 602(1):78-84. PubMed ID: 19026629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin 1 Prevents Phencyclidine-Induced Behavioral Impairments and Disruptions to GABAergic Signaling in Mice.
    Engel M; Snikeris P; Jenner A; Karl T; Huang XF; Frank E
    Int J Neuropsychopharmacol; 2015 May; 18(7):pyu114. PubMed ID: 26478928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivity of endoplasmic reticulum associated exocytosis mechanism contributes to acute phencyclidine intoxication.
    Zhu G; Okada M; Uchiyama D; Ohkubo T; Yoshida S; Kaneko S
    J Pharmacol Sci; 2004 Jun; 95(2):214-27. PubMed ID: 15215646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
    Abdul-Monim Z; Neill JC; Reynolds GP
    J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: implications for abnormalities of glutamate release and NMDA-CaMKII signaling.
    Murai R; Noda Y; Matsui K; Kamei H; Mouri A; Matsuba K; Nitta A; Furukawa H; Nabeshima T
    Behav Brain Res; 2007 Jun; 180(2):152-60. PubMed ID: 17451820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia-like GABAergic gene expression deficits in cerebellar Golgi cells from rats chronically exposed to low-dose phencyclidine.
    Bullock WM; Bolognani F; Botta P; Valenzuela CF; Perrone-Bizzozero NI
    Neurochem Int; 2009 Dec; 55(8):775-82. PubMed ID: 19651169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
    Jodo E
    J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine.
    Kargieman L; Santana N; Mengod G; Celada P; Artigas F
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14843-8. PubMed ID: 17785415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.
    Yonezawa Y; Kuroki T; Kawahara T; Tashiro N; Uchimura H
    Eur J Pharmacol; 1998 Jan; 341(1):45-56. PubMed ID: 9489855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.